Valuation Mesa Laboratories, Inc.
Stocks
MLAB
US59064R1095
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
01:30:00 20/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 123.30 USD | +0.67% |
|
-3.72% | +57.08% |
Company Valuation: Mesa Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,337 | 934.1 | 591.9 | 644.8 | 488.5 | 690 | - |
| Change | - | -30.14% | -36.64% | 8.93% | -24.23% | 41.25% | - |
| Enterprise Value (EV) | 1,506 | 1,084 | 591.9 | 644.8 | 488.5 | 690 | 690 |
| Change | - | -27.99% | -45.42% | 8.93% | -24.23% | 41.25% | 0% |
| P/E | 728x | 1,028x | -2.32x | -330x | 73.1x | 58x | 44.4x |
| PBR | 3.41x | 2.38x | 4.07x | 4.05x | 2.62x | 3.53x | 3.21x |
| PEG | - | -20x | 0x | 3.3x | -0x | 0.8x | 1.5x |
| Capitalization / Revenue | 7.25x | 4.26x | 2.74x | 2.68x | 1.96x | 2.71x | 2.55x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 2.71x | 2.55x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 11.2x | 9.84x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 11.4x | 10.5x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 15.5x | 14.8x |
| FCF Yield | 2.6% | 2.51% | 7.02% | 6.6% | 8.1% | 6.43% | 6.77% |
| Dividend per Share 2 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 |
| Rate of return | 0.25% | 0.37% | 0.58% | 0.54% | 0.72% | 0.52% | 0.52% |
| EPS 2 | 0.35 | 0.17 | -47.2 | -0.36 | 1.21 | 2.125 | 2.775 |
| Distribution rate | 183% | 376% | -1.36% | -178% | 52.9% | 30.1% | 23.1% |
| Net sales 1 | 184.3 | 219.1 | 216.2 | 241 | 249.1 | 254.4 | 270.8 |
| EBITDA 1 | 41.16 | 49.68 | 50.5 | 56.74 | 63.49 | 61.4 | 70.1 |
| EBIT 1 | 37.9 | 45.82 | 50.5 | 51.36 | 58.23 | 60.5 | 65.9 |
| Net income 1 | 1.871 | 0.93 | -254.2 | -1.974 | 6.712 | 12.7 | 17.35 |
| Net Debt | 169 | 150.4 | - | - | - | - | - |
| Reference price 2 | 254.88 | 174.73 | 109.73 | 118.66 | 88.42 | 123.30 | 123.30 |
| Nbr of stocks (in thousands) | 5,246 | 5,346 | 5,394 | 5,434 | 5,525 | 5,596 | - |
| Announcement Date | 31/05/22 | 25/05/23 | 05/06/24 | 28/05/25 | 27/05/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 58.03x | - | - | 0.52% | 69Cr | ||
| 30.7x | 4.06x | 15.71x | 2.44% | 18TCr | ||
| 19.83x | 3.46x | 12.37x | 3.06% | 11TCr | ||
| 23.23x | 4.55x | 15.85x | 1.21% | 11TCr | ||
| 26.93x | 2.64x | 10.6x | 2.68% | 7.84TCr | ||
| 18.65x | 0.21x | 13.46x | 0.7% | 6.49TCr | ||
| 31.09x | 7.72x | 19.92x | 1.28% | 5.4TCr | ||
| 36.76x | 3.52x | 12.05x | 2.06% | 5.2TCr | ||
| 37.64x | 9.35x | 26.14x | -.--% | 4.38TCr | ||
| 34.55x | 6.06x | 19.02x | -.--% | 3.24TCr | ||
| Average | 31.74x | 4.62x | 16.13x | 1.39% | 7.34TCr | |
| Weighted average by Cap. | 27.46x | 4.19x | 15.29x | 1.85% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- MLAB Stock
- Valuation Mesa Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
















